文献速递心力衰竭与心肌病心律失常肺血管病与心包/心肌炎

一例COVID-19患者从轻症到危重症的临床特征变化及心肺病理结果

[Clinical feature changes of a COVID-19 patient from mild to critical condition and cardiopulmonary pathological results].
PubMed 文献 · Zhonghua Xin Xue Guan Bing Za Zhi · 2020-01-01

该个案报告回顾性分析1例COVID-19患者从轻症快速进展至危重症的临床与心肺病理资料。患者感染后第9天入院,第12天重症、第18天危重症,第28至45天接受ECMO、CRRT及心肺联合移植,术后第2天死亡。病理示弥漫性肺出血损伤坏死、纤维化、小血管病变及心肌水肿和淋巴细胞浸润。

要点

  • COVID-19可从轻症快速进展为危重症并累及肺、心和肝。
  • 病毒核酸检测转阴后病情仍可加重,需持续监测器官功能。
  • 肺病理以弥漫性出血坏死、纤维化及小血管病变为主。

核心结论

  • COVID-19危重型患者从轻症到危重症及死亡进展快速,危重症阶段可发生肺、心和肝脏损伤。

研究设计与样本

  • 回顾性分析1例COVID-19患者从发病到危重型快速进展过程中的临床指标、实验室检查、支气管镜及超声心动图结果和心肺病理解剖结果。

主要发现

  • 患者在2019新型冠状病毒感染后第9天入院,起病后从轻症到重症、重症到危重症分别经历12和18 d。
  • 患者在第28至45天期间接受体外膜肺氧合联合连续性肾脏替代疗法及心肺联合移植术,术后第2天死亡。
  • 早期症状轻,炎症指标升高、淋巴细胞减少;多次病毒核酸检测转阴后病情仍加重。
  • 病情进展为肺出血和实变、肺动脉高压、右心衰竭、恶性心律失常及肝功能异常。
  • 肺病理可见气管及支气管内大量黏液、暗红色分泌物和血块,主要为肺组织出血坏死、肺泡炎、纤维素性渗出和小血管病变,心肌细胞水肿和少量炎症细胞浸润。

临床怎么用

  • 对COVID-19患者应动态监测炎症指标、淋巴细胞及心肺肝功能,警惕轻症快速进展为危重症。

局限性

  • 为单一病例的回顾性分析,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To analyse the clinical history, laboratory tests and pathological data of a patient who suffered from novel coronavirus pneumonia(COVID-19) and provide reference for the clinical treatment of similar cases. Methods: Data of clinical manifestation, laboratory examination, bronchoscopy, echocardiography and cardiopulmonary pathological results were retrospectively reviewed in a case of COVID-19 with rapid exacerbation from mild to critical condition. Results: This patient hospitalized at day 9 post 2019 novel coronavirus(2019-nCoV) infection, experienced progressive deterioration from mild to severe at day 12, severe to critical at day 18 and underwent extracorporeal membrane oxygenation(ECMO) and continuous renal replacement therapy(CRRT) as well as heart lung transplantation during day 28-45 post infection, and died at the second day post heart and lung transplantation. The patient had suffered from hypertension for 8 years. At the early stage of the disease, his symptoms were mild and the inflammatory indices increased and the lymphocyte count decreased continuously. The patient's condition exacerbated rapidly with multi-organ infections, and eventually developed pulmonary hemorrhage and consolidation, pulmonary hypertension, right heart failure, malignant ventricular arrhythmias, liver dysfunction, etc. His clinical manifestations could not be improved despite viral RNAs test results became negative. The patient underwent lung and heart transplantation and finally died of multi organ failure at the second day post lung and heart transplantation. Pathological examination indicated massive mucus, dark red secretions and blood clots in bronchus. The pathological changes were mainly diffused pulmonary hemorrhagic injuries and necrosis, fibrosis, small vessel disease with cardiac edema and lymphocyte infiltration. Conclusions: The clinical course of severe COVID-19 can exacerbate rapidly from mild to critical with lung, liver and heart injuries. 目的: 分析新型冠状病毒肺炎(COVID-19)危重型患者的临床资料和心肺病理特征,为类似病例的临床救治提供借鉴。 方法: 回顾性分析1例COVID-19患者从发病到危重型快速进展过程中的临床指标、实验室检查、支气管镜及超声心动图结果的动态变化和心肺病理解剖结果。 结果: 该例患者在2019新型冠状病毒(2019-nCoV)感染后第9天入院。患者起病后从轻症到重症,再到危重症分别经历了12和18 d,在第28至45天期间接受了体外膜肺氧合(ECMO)联合连续性肾脏替代疗法(CRRT)以及心肺联合移植术,术后第2天死亡。患者有8年高血压病史。早期症状轻,炎症指标升高、淋巴细胞减少。治疗效果差,病情进展迅速,多次病毒核酸检测转阴之后病情仍加重,并逐渐发展为肺出血和实变,大量分泌物和肺内出血导致肺功能丧失、肺动脉高压、右心衰竭、恶性心律失常及肝功能异常。予右肺移植和原位心脏移植术后不能维持循环稳定而死亡。肺病理检查可见气管及支气管内存在大量黏液、暗红色分泌物和血块,病理改变主要为肺组织出血坏死、肺泡炎、纤维素性渗出和小血管病变,心肌细胞水肿和少量炎症细胞浸润。 结论: COVID-19危重型患者从轻症到危重症、死亡进展快速,危重症阶段发生肺、心和肝脏损伤。.

来源:Zhonghua Xin Xue Guan Bing Za Zhi,查看原文。版权归原作者所有。

引用

  1. Jiang SW, Gao H, Wu L, et al. [Clinical feature changes of a COVID-19 patient from mild to critical condition and cardiopulmonary pathological results]. Zhonghua Xin Xue Guan Bing Za Zhi. 2020. PMID: 32455515. doi:10.3760/cma.j.cn112148-20200304-00155

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。